Chilivis Grubman LLP
  • Home
  • Firm Overview
  • Attorneys
    • Scott R. Grubman
    • Lauren A. Warner
    • Jeremy T. Berry
    • Brittany M. Cambre
    • Joseph J. Siegelman
    • Hakim Hilliard
    • Sanjay Karnik
    • Brandi Z. Murrain
    • Maiysha Rashad
  • Practice Areas
    • Healthcare
      • Government Investigations & Litigation
      • Payor Audits and Audit Appeals
      • HIPAA and Cybersecurity
      • Medical Board Investigations
      • Peer Review & Credentialing Disputes
      • Healthcare Regulatory Compliance
    • Civil and Business Litigation
      • Class Action Defense
    • Criminal Defense
      • White Collar Crime
      • Healthcare Fraud
      • Public Corruption
      • Internal Investigations
    • False Claims Act and Qui Tam Defense
    • Data Privacy & Cybersecurity
    • Internal Investigations
    • Government Affairs
      • Advocacy and Regulatory Affairs
      • Government Contracts
      • Government Litigation and Administrative Law
      • Advertising Compliance
      • Land Use & Zoning
      • Licensing and Permits
    • Campaign Finance and Election Law
    • Entertainment Law & Artist Management
      • Trademark, Copyright, and Brand Protection
  • Blog
  • News
  • Insights
  • Contact
Select Page

Pharmaceutical Giant Biogen Pays Nearly $1 Billion to Resolve False Claims Act Matter

Sep 29, 2022 | False Claims Act, Government Investigations, Health Care Fraud

On September 26, 2022, the Department of Justice (DOJ) announced that pharmaceutical giant Biogen, Inc. agreed to pay $900 million to resolve allegations that it violated the False Claims Act (FCA) by paying prescribing physicians kickbacks in exchange for prescribing...

Reminder: Insufficient Cyber Security Can Lead to an FCA Case

Sep 19, 2022 | False Claims Act

The False Claims Act (“FCA”) continues to be a significant tool for the government to ensure compliance with companies that contract with the United States.  The FCA prohibits any person from knowingly presenting, or causing to be presented, a false or fraudulent...

Medicare Revoked Podiatrist Convicted for $1.8 Million Healthcare Fraud Scheme to Bill Medicare Despite Revocation

Sep 19, 2022 | White Collar Crime

The revocation of Medicare billing privileges can significantly affect providers and often results in a snowball effect, where the revoked provider is scrutinized by private employers and privilege-granting institutions.  Revoked providers can lose facility...

Georgia Attorney Denied Voluntary Suspension to Remedy Mishandling Several Cases

Sep 19, 2022 | State Bar of Georgia Investigations

On September 7, 2022, the Georgia Supreme Court denied attorney Andrew Matteson’s petition for a voluntary six-month suspension after admitting he mishandled several client matters. Matteson acknowledged he violated various Georgia Rules of Professional Conduct, but...

Former City of Atlanta Executive Sentenced to 14 Years in $17 Million Bribery Scheme

Sep 19, 2022 | White Collar Crime

On Thursday, September 8, 2022, U.S. District Judge Steve C. Jones sentenced a former City of Atlanta executive to 14 years in prison and ordered her to pay $2.9 million in restitution. Mitzi Bickers, 56, was the director of Atlanta’s human services department from...

Justice Department Seeks to Shut Down Texas Tax Preparer

Sep 19, 2022 | federal investigations

Tax return preparer fraud is one of the IRS’ Dirty Dozen Tax Scams, and the government continues in its efforts to eradicate it as such. On September 7, 2022, Assistant Attorney General David A. Hubbert advised “taxpayers seeking a return preparer should remain...

The 11th Circuit Upholds Ruling that Employee Must Meet Objectively Reasonable Belief Standard to Recover for Retaliation Under FCA

Sep 7, 2022 | False Claims Act

The Eleventh Circuit agreed with a Florida district court’s ruling that an employee needs “at least an objectively reasonable belief” that they engaged in protected conduct to recover for retaliation under the False Claims Act (FCA), and the FCA does not cover general...

President of Company with “Revolutionary” Blood Testing Technology convicted in $77 Million COVID-19 and Allergy Testing Scheme

Sep 7, 2022 | federal investigations

On September 2, 2022, the U.S. Department of Justice announced the conviction of Mark Schena of California.  Mr. Schena was the president of Arrayit Corporation, a Silicon Valley-based medical technology company.  According to the press release, Mr. Schena claimed to...

Bayer Agrees to Pay $40 Million to Resolve the Alleged Use of Kickbacks and False Statements Relating to Three Drugs

Sep 7, 2022 | Health Care Fraud

On September 2, the Department of Justice announced, “Bayer Corporation, an Indiana corporation and manufacturer of pharmaceutical products, and its related entities, Bayer HealthCare Pharmaceuticals Inc., Bayer HealthCare LLC and Bayer AG (collectively “Bayer”), have...

District Judge Grants President Trump’s Request for a Special Master

Sep 5, 2022 | Government Investigations, White Collar Crime

On September 5, 2022, United States District Judge Aileen Cannon, of the Southern District of Florida, issued an Order granting in part former president Donald Trump’s “Motion for Judicial Oversight and Additional Relief.”  In that motion, President Trump asked that...
« Older Entries
Next Entries »

Recent Posts

  • With Bivens on Life Support, FTCA May Be Viable Option for Claims Against ICE
  • Does the ICE Agent Who Killed Renee Good Really Have Immunity?
  • False Claims Act Recoveries Exceed $6.8B in FY2025; Highest Ever
  • Kaiser Agrees to $556 Million False Claims Act Settlement
  • Skin Substitute Medicare Audits: Is Round Two on the Horizon?

Categories

  • A.I. Law
  • Accessory Dwelling Units
  • Administrative Law
  • Anti-Counterfeit
  • Atlanta News
  • Brand Protection
  • Business Litigation
  • Civil Healthcare Litigation
  • Civil Matters
  • Civil Rights
  • Code Enforcement
  • Commercial Litigation
  • Commercial Payor Audits
  • Complex Criminal Litigation
  • Copyright Infringement
  • COVID-19 Related Law
  • Criminal Matters
  • Cyber Law
  • Data Breach
  • Defamation
  • DMEPOS
  • DOJ
  • Drug Policy Law
  • Election Law
  • Employment Law
  • Environmental
  • False Claims Act
  • federal investigations
  • Federal Tax Investigations
  • FINRA
  • Firm Announcement
  • FOIS Compliance
  • Fraud Investigations
  • General
  • Government Affairs
  • Government Contract
  • Government Investigations
  • Government Litigation
  • Health Care
  • Health Care Fraud
  • Healthcare Transactions
  • Hemp & Cannabis
  • Hemp and Cannabis
  • HIPAA
  • Housing Development Law
  • Land Use Law
  • Land Zoning Law
  • Liquor Law
  • Medicare and Medicaid
  • Non-Profit Organizations
  • ommercial payor audits
  • Open Records Act
  • Overpayment Appeals
  • PPP Investigations
  • Public Corruption
  • Restrictive Covenants
  • SEC Investigations
  • Special Use Permit Filing
  • State Bar of Georgia Investigations
  • Strategic Land Use
  • Tax Fraud
  • toxic tort
  • Trade Law
  • Trademark Enforcement
  • Trademark Protection
  • Tree Ordinance
  • Uncategorized
  • Variances
  • White Collar Crime
  • Zoning and Land Use
Built by The Montgomery Group